I. General information |
Synonyms: |
KYSE-520 |
Background: |
established from the moderately differentiated invasive eosphageal squamous cell carcinoma resected from lower intra-thoracic esophagus of a 58-year-old Japanese woman prior to treatment (tumor had invaded the adventitia); described as carrying p53 mutation and amplification of the oncogene MYC |
Species: |
human (Homo sapiens) |
Tissue: |
esophageal |
Disease: |
esophageal squamous cell carcinoma |
Gender: |
N/A |
Morphology: |
epitheloid cells growing adherently as monolayers, occasional giant cells present (ca. 1%); |
Growth Mode: |
N/A |
Doubling Time: |
ca. 30 hours |
DNA Profile: |
N/A
Our Cell Line Authentication Service |
Culture Medium: |
RPMI-1640+10%FBS
KYSE-520完全培養(yǎng)基,# CBP60658M
We strongly suggest to purchase the complete medium from us.
|
Cryopreservation medium: |
90%FBS+10%DMSO |
Mycoplasma: |
negative in DAPI, microbiological culture, RNA hybridization, PCR assays |
Immunology: |
cytokeratin +, cytokeratin-7 -, cytokeratin-8 +, cytokeratin-17 +, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin + |
Fingerprint: |
multiplex PCR of minisatellite markers revealed a unique DNA profile |
Species: |
originally confirmed as human with IEF of AST, LDH, MDH and later by STR profiling |
Cytogenetics: |
human flat-moded hypotriploid karyotype with 8% polyploidy - 58-60<3n>XX, -X, +1, +1, -2, -2, -4, -5, -6, +7, -8, -10, -10, -11, -12, -12, -13, -14, -15, -16, -17, -18, +20, +20, -21, -21, -22, -2, +7-8mar, add(X)(p11), add(X)(q11), add(1)(q11), der(1)del(1)(q12)t(1;7)(p36;q21), der(1)del(1)(q12)t(1;5)(p36;q11), del(1)(q21), del(1)(p34), add(2)(q37), del(3)(q13), add(4)(p11), add(4)(p15), add(5)(q11)x1-2, add(6)(q1?), t(6;15)(p10;q10)x1-2, del(7)(q11)x1-2, add(7)(p22), add(9)(p23), der(11)add(11)(p15)t(11;12)(q24;q11), add(11)(p15), add(16)(q2?3), add(17)(q24), add(18)(p11), add(19)(p13)del(22)(q13) |
Virus |
ELISA: reverse transcriptase negative; PCR: EBV -, HBV -, HCV -, HHV-8 -, HIV-1 -, HIV-2 -, HPV -, HTLV-I/II -, MLV -, SMRV - |
Comments: |
For more information, please contact us (4008-750-250). |